A possible role in chemical carcinogenesis for epigenetic, heritable changes in gene expression

Molecular Carcinogenesis

Volumn 15, Issue 4, 1996, Pages 241-250

  MacLeod, Michael C ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Autoregulatory transcription factors; Bistable steady state; Epigenetic mechanisms; Selector genes

Indexed keywords

CANCER GENETICS; CHEMICAL CARCINOGENESIS; GENE EXPRESSION; HYPOTHESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; CARCINOGENS; CHROMATIN; DNA-BINDING PROTEINS; GENE EXPRESSION; GENES, REGULATOR; HELIX-LOOP-HELIX MOTIFS; METHYLATION; MODELS, BIOLOGICAL; NEOPLASMS; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS;

EID: 0029981431     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199604)15:4<241::AID-MC1>3.0.CO;2-J     Document Type: Review

References (58)

1. Boveri TH. Zur Frage der Entstehung maligner Tumoren. Fischer, Jena, Germany, 1914
2. Weinberg RA Oncogenes, tumor suppressor genes and cell transformation: Trying to put it all together In: Brugge J, Curran T, Harlow E, McCormick F (eds), Origins of Human Cancer, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1991, pp. 1-16
3. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 253 49-53, 1991.
4. Marshall CJ, Vousden KH, Phillips DH. Activation of c-Ha-ras-1 proto-oncogene by in vitro modification with a chemical carcinogen, benzo[a]pyrene diol epoxide. Nature 310:586-589, 1984
5. Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233-1238, 1990
6. Rubin H. Is somatic mutation the major mechanism of malignant transformation? J Natl Cancer Inst 64:995-1000, 1980.
7. Kennedy AR Is there a critical target gene for the first step in carcinogenesis? Environ Health Perspect 93.199-203, 1991.
8. Holliday R. Mutations and epimutations in mammalian cells. Mutat Res 250-351-363, 1991.
9. Kamiya K, Yasukawa-Barnes J, Mitchen JM, Gould MN, Clifton KH. Evidence that carcinogenesis involves an imbalance between epigenetic high-frequency initiation and suppression of promotion. Proc Natl Acad Sci USA 92 1332-1336, 1995.
10. Selvanayagam CS, Davis CM, Cornforth MN, Ullrich RL. Latent expression of p53 mutations and radiation-induced mammary cancer. Cancer Res 55.3310-3317, 1995.
11. Mondal S, Heidelberger C In vitro malignant transformation by methylcholanthrene of the progeny of single cells derived from C3H mouse prostate. Proc Natl Acad Sci USA65:219-225, 1970.
12. Barrett JC, T'so POP. Relationship between somatic mutation and neoplastic transformation. Proc Natl Acad Sci USA 75 3297-3301, 1978
13. Kennedy AR, Fox M, Murphy G, Little JB. Relationship between x-ray exposure and malignant transformation inCSH 10T1/2 cells Proc Natl Acad Sci USA 77.7262-7266, 1980.
14. Terzaghi-Howe M Induction of preneoplastic alterations by X-rays and neutrons in exposed rat tracheas and isolated tracheal epithelial cells Radiat Res 120.352-353, 1989.
15. Zhang R, Haag JD, Gould MN. Quantitating the frequency of initiation and c-H-ras mutation in in situ N-methyl-N-nitrosourea-exposed rat mammary gland Cell Growth Differ 2:1-6, 1991.
16. Pitot HC, Heidelberger C Metabolic regulatory circuits and carcinogenesis. Cancer Res 23.1694-1700, 1963.
17. Jacob F, Monod J. On the regulation of gene activity. Cold Spring Harb Symp Quant Biol 26:193-209, 1961.
18. Blanchi AB, Frscher SM, Robles AI, Rinchik EM, Conti CJ. Overexpression of cyclm D1 in mouse skin carcinogenesis. Oncogene 8:1127-1133, 1993.
19. Schauer IE, Siriwardana S, Langan TA, Sclafani RA. Cyclin D1 Overexpression vs. retinoblastoma inactivation: Implications for growth control evasion in non-small cell and small cell lung cancer. Proc Natl Acad Sci USA 91:7827-7831, 1994.
20. Kraus MNI, Popescu NC, Amsbaugh SC, King CR Overexpression of the EGF receptor-related proto-oncogene erbB2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J 6:605-610, 1987.
21. van de Vivjer MJ, Paterse JL, Mooi WJ, et al. Neu-protein overexpression in breast cancer. New Engl J Med 319:1239-1245, 1988.
22. Halder G, Callaerts P, Gehring WJ. Induction of ectopic eyes by targeted expression of the eyeless gene in Drosophila. Science 267:1788-1792, 1995
23. Shivdasani RA, Mayer EL, Orkin SH. Absence of blood formation in mice lacking the T-cell leukemia oncoprotein tal-1/SCL. Nature 373:432-434, 1995.
24. Lee JE, Hollenberg SM, Snider L, Turner DL, Lipnick N, Weintraub H. Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein. Science 268:836-844, 1995.
25. MacDougald OA, Lane MD. Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem 54.345-373, 1995.
26. Weintraub H, Davis R, Tapscott S, et al. The myoD gene family: Nodal point during specification of the muscle cell lineage Science 251:761-766, 1991.
27. Weintraub H. The MyoD family and myogenesis: Redundancy, networks, and thresholds. Cell 75:1241-1244, 1993.
28. Kalthoff K Analysis of Biological Development McGraw-Hill, New York, 1996
29. Holtfreter JF. A new look at Spemann's organizer. In. Browder LW (ed), The Molecular Biology of Cell Determination and Cell Differentiation, Plenum, New York, 1985, pp. 127-150.
30. Gehring W The stability of the determined state in cultures of imaginal disks in Drosophila. In: Ursprung H, Nothiger R (eds), The Biology of Imaginai Disks, Springer-Verlag, New York, 1972, pp. 35-58.
31. Wallrath LL, Elgin SCR. Position effect variegation in Drosophila is associated with an altered chromatin structure. Genes Dev 9-1263-1277, 1995.
32. Tilghman SM, Bartolomei MS, Webber AL, et al. Parental imprinting of the H19 and lgf2 genes in the mouse. Cold Spring Harb Symp Quant Biol 58:287-295, 1993
33. Weintraub H. Assembly and propagation of repressed and derepressed chromosomal states. Cell 42-705-711, 1985
34. Kauffman SA. Control circuits for determination and transdetermination. Science 181-310-318, 1973.
35. Schter AF, Gehring WJ Direct homeodomain-DNA interaction in the autoregulation of the fushi tarazu gene. Nature 356:804-807, 1992
36. Krasnow MA, Saffman EE, Kornfeld K, Hogness DS Transcriptional activation and repression by Ultrabithorax proteins in cultured Drosophila cells Cell 57.1031-1043, 1989.
37. Johnson DG, Ohtani K, Nevins JR. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression Genes Dev 8.1514-1525, 1994.
38. DeGregori J, Kowalik T, Nevins JR. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis-and G1/ S-regulatory genes Mol Cell Biol 15:4215-4224, 1995
39. Keller AD Specifying epigenetic states with autoregulatory transcription factors. J Theor Biol 170:175-181, 1994.
40. Keller AD Model genetic circuits encoding autoregulatory transcription factors. J Theor Biol 172:169-185, 1995
41. Wolffe AP. Nucleosome positioning and modification. Chromatin structures that potentiate transcription. Trends Biochem Sci 19.240-244, 1994.
42. Cusick ME, Lee K-S, DePamphilis ML, Wasserman PM. Structure of chromatin at DNA replication forks Nuclease hypersensitivity results from both prenucleosomal DNA and an immature chromatin structure Biochemistry 22:3873-3884, 1983.
43. Paules RS, Cordeiro-Stone M, Mass MJ, Poirier MC, Yuspa SH, Kaufman DG. Benzo[a]pyrene diol epoxide I binds to DNA at replication forks Proc Natl Acad Sci USA 85:2176-2180, 1988.
44. MacLeod MC, Kootstra A, Mansfield BK, Slaga TJ, Selkirk JK. Specificity in interaction of benzo[a]pyrene with nuclear macromolecules. Implication of derivatives of two dihydrodiols in protein binding. Proc Natl Acad Sci USA 77.6396-6400, 1980.
45. Tunek A, Schelin C, Jergil B. Microsomal target proteins of metabolically activated aromatic hydrocarbons. Chem Biol Interact 27:133-144, 1979.
46. Razin A, Cedar H. DNA methylation and gene expression. Microbiol Rev 55:451-456, 1991.
47. Baylin SB, Makos M, Wu JJ, et al Abnormal patterns of DNA methylation in human neoplasia Potential consequences for tumor progression Cancer Cells 3:383-390, 1991
48. Makos M, Nelkin BD, Lerman MI, Latif F, Zbar B, Baylin SB. Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer Proc Natl Acad Sci USA 89:1929-1933, 1992.
49. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 7:536-540, 1994.
50. Macleod D, Charlton J, Mullins J, Bird AP. Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev 8:2282-2292, 1994.
51. Boles TC, Hogan ME High-resolution mapping of carcinogen binding sites on DNA. Biochemistry 25:3039-3043, 1986.
52. Kootstra A, Lew LK, Nairn RS, MacLeod MC. Preferential modification of GC boxes by benzo[a]pyrene-7,8-diol-9,10 epoade Mol Carcinog 1:239-244, 1989.
53. Treiber DK, Zhai X, Jantzen H-M, Essigman JM. Cisplatin-DNA adducts are molecular decoys for the ribosomal transcription factor hUBF (human upstream binding factor). Proc Natl Acad Sci USA 91:5672-5676, 1994.
54. MacLeod MC, Powell KL, Tran N Binding of the transcription factor, Sp1, to non-target sites in DNA modified by benzo[a]pyrene diol epoxtde. Carcinogenesis 16:975-983, 1995
55. Sun D, Hurley LH. TBP binding to the TATA box induces a specific downstream unwinding site that is targeted by pluramycin Chemistry & Biology 2.457-469, 1995.
56. Dorn A, Affolter M, Muller M, Gehring WJ, Leupin W. Distamycin-induced inhibition of homeodomain-DNA complexes. EMBO J 11:279-286, 1992
57. Beachy PA, Krasnow MA, Gavis ER, Hogness DS An Ultrabithorax protein binds sequences near its own and the Antennapedia P1 promoters. Cell 55 1069-1081, 1988.
58. Winslow GM, Hayashi S, Krasnow M, Hogness DS, Scott MP Transcriptional activation by the Antennapedia and fushi tarazu proteins in cultured Drosophiia cells. Ceil 57:1017-1030, 1989.